In a new study, an experimental obesity drug from Novo Nordisk, CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company's stock price to fall by as much as 29%. Yes, fall. For anyone not following the heated race for obesity drug dominance, it may look like we're living upside-down. After all, if this data were unveiled three years ago, the market reaction would have been wildly different. The stock might have gone up and headlines would have heralded an advance in the fight against obesity. But we're in a new era of obesity medicine. The bar for success, once modest, has soared—especially so for CagriSema. Let me explain.
Though Novo will make mind-blowing money from its existing obesity drugs in the coming years (its GLP-1 drugs are likely to become pharma's most lucrative franchise next year), CagriSema was seen as essential for continued growth in 2030 and beyond. And the study suggests it may not be the contender investors had hoped for.
This story is from the January 02, 2025 edition of Mint Bangalore.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the January 02, 2025 edition of Mint Bangalore.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
States' Q4 borrowing to rise 18% after Q2 growth slump
Capex boost likely as West Bengal, Maharashtra, Karnataka lead ₹4.73 tn borrowing plan
Cold wave in North India to boost wheat, mustard crops
The drop in temperature does not bode well for crops like chickpea and potatoes in the plains
Govt cuts gas allocation for LPG, diverts to city retailers
The government has slashed allocation of natural gas used for liquefied petroleum gas (LPG) production, and diverted the low-priced fuel to city gas retailers like Indraprastha Gas Ltd and Adani-Total Gas Ltd to meet part of their requirement for compressed natural gas (CNG)/piped cooking gas supplies, said an official order.
Rupee closes at new record low vs dollar
Reports of the central bank selling US dollars supported the rupee at lower levels, traders said
Existing EV subsidies to stay, no new incentives
Commerce minister Piyush Goyal said on Friday existing subsidies for the electric vehicle (EV) ecosystem will continue for some time, citing broad consensus among the government, auto OEMs, and battery swapping companies that no new incentives or subsidies are required at this stage.
Pharma Teachers Faking Profiles to Be Blacklisted
Pharmacy Council of India Identified 45,355 Cases of Duplicate Profiles on Digi-Pharmed Portal Using Same Aadhaar and PAN
India's market cap share globally dips from record highs
India's share in global market capitalization dipped to 4.2% in December from its August peak of 4.6%, as global equity markets faced turbulence, showed an analysis by Motilal Oswal Financial Services Ltd.
PM E-Drive e-bus subsidy to be rolled out from March
Govt to initiate bidding process after working out demand via state, city transport utilities
PNG, CNG Consumers to Get Uniform Insurance Cover
Although CNG Users Report More Accidents, Instances of Pipeline Leaks at PNG Households Were Reported
Biden to Block Sale of US Steel to Nippon
President Joe Biden has decided to block the sale of United States Steel Corp. to Japan's Nippon Steel Corp., according to three people with knowledge of the matter, ending a $14.1 billion deal that has faced months of vocal opposition and raising questions over the future of a US industrial giant.
